The interaction of MSC VCAM1 with leukemic cells VLA4 has been shown to be relevant for chemotherapy resistance in AML and ALL by a NF-κB-mediated mechanism [43, 44]. This evidence concerns the gene NFKB1 and acute lymphoblastic leukemia.